*Novartis move adds to Big Pharma retreat from antibiotics R&D. ZURICH, Aug 20- Novartis has signed a licensing deal to hand over its experimental tuberculosis drugs to the Global Alliance for TB Drug Development, joining a growing Big Pharma retreat from antibiotics.» Read More
May 19- Ophthotech Corp said it could potentially receive over $1 billion in payments as part of a licensing deal for its experimental eye drug with Novartis AG. Ophthotech's shares rose as much as 29 percent in trading after the bell.
*Working on more tiered pricing after deal with Egypt. LONDON, April 8- Gilead Sciences aims to license its new hepatitis C drug Sovaldi to three or four Indian generic manufacturers to allow sales of the medicine at lower prices in some 60 developing nations.